Wednesday, June 16, 2021

CHI Health to use new antibody drug to treat COVID patients

LINCOLN, Neb. (KOLN) – On Friday, November 20, CHI Well being will start infusing certified, physician-referred sufferers with Bamlanivimab, an antibody drug that acquired emergency use authorization from the FDA to assist deal with COVID-19.

CHI Well being acquired its provide from the federal authorities, which was then allotted by DHHS. The 14-hospital system has provide for 344 infusions throughout its Nebraska hospital areas and 39 doses for sufferers in Iowa. Essential entry hospitals will even have entry to this provide.

So as to obtain a Bamlanivimab infusion, sufferers will want a constructive COVID-19 take a look at, be at a excessive threat for hospitalization and have a referral from a doctor. The affected person will then need to consent to the remedy.

Within the Metro, CHI Well being Midlands will function CHI Well being’s infusion space and can be open eight hours a day, seven days per week beginning on Friday. In Lincoln, Kearney, Council Bluffs, Grand Island and significant entry areas, infusion websites can be designated at every hospital location.

Copyright 2020 KOLN. All rights reserved.

Source link

Next Post

Recent News